0001127602-21-024865.txt : 20210903 0001127602-21-024865.hdr.sgml : 20210903 20210903160919 ACCESSION NUMBER: 0001127602-21-024865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: APPIO THOMAS CENTRAL INDEX KEY: 0001683323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 211236577 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-09-01 0000885590 Bausch Health Companies Inc. BHC 0001683323 APPIO THOMAS 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 Pres&Co-Head Bausch&Lomb/Int'l Common Shares, No Par Value 2021-09-01 4 A 0 90260 0 A 320686 D Restricted Share Units 0 2021-09-01 4 A 0 90260 0 A Common Shares, No Par Value 90260 90260 D Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. /s/ Kirsten O'Donnell, attorney-in-fact for Thomas Appio 2021-09-03